S-Gal (3,4-Cyclohexenoesculetin-β-D-galactopyranoside, CAS 182805-65-8), commercially known as S-Gal®, represents a superior chromogenic substrate to X-Gal for β-galactosidase (β-Gal, EC 3.2.1.23) detection, hydrolyzing the β-glycosidic bond to release 3,4-cyclohexenoesculetin that chelates ferric ions (Fe³⁺) forming an intense black insoluble precipitate with strong T₂* MRI contrast enhancement, enabling both histological visualization and noninvasive molecular imaging. With molecular formula C19H22O9 (MW 394.38 g/mol), this white crystalline solid features β-D-galactopyranose linked at C1-O to the enol form of cyclohexenoesculetin—a coumarin derivative with vicinal hydroxy groups at positions 3,4—exhibiting rapid cleavage by E. coli lacZ (α-complementation), mammalian lysosomal β-galactosidases, and viral β-Gals (kcat/Km >10⁴ M⁻¹s⁻¹), producing the catechol-like aglycone that quantitatively binds Fe³⁺ (1:2 stoichiometry) to generate superparamagnetic nanoscale precipitates detectable by eye, absorbance (λmax 590 nm), and MRI (ΔR₂* >100 s⁻¹mM⁻¹). Unlike X-Gel’s diffusion-prone indigo, S-Gal’s nondiffusible black product localizes precisely to enzyme sources, supporting high-density colony screening (>10⁴ CFU/plate) with 2-4x faster color development (visible at 4h vs. 16h), while Fe³⁺ complexation enables multimodal readout (histology/MRI/optical) for in vivo reporter gene imaging in lacZ-transfected tumor xenografts. Used at 100-200 μg/mL with 0.5-2 mM ferric ammonium citrate (FAC), it revolutionizes molecular imaging by bridging traditional histology with clinical MRI, with applications in gene therapy monitoring, oncolytic virotherapy tracking, and real-time β-Gal pharmacodynamics without ionizing radiation.
Appearance
White crystalline powder.
Hydrolysis + Fe³⁺ yields black insoluble precipitate.
Source
Glycosylation of 3,4-cyclohexenoesculetin with protected β-D-galactopyranosyl donor.
Reviews
There are no reviews yet.